Wu, H. et al. Isobaric tags for relative and absolute quantitation in proteomic evaluation of potential biomarkers in invasive most cancers, ductal carcinoma in situ, and mammary fibroadenoma. Entrance. Oncol. 10, 574552 (2020).
IARC. New World Most cancers Knowledge: GLOBOCAN 2020. Int. Company Res. Most cancers 6 (2020).
WHO. Globocan 2020. Worldwide Company for analysis vol. 419 3–4 https://ascopost.com/information/december-2020/globocan-2020-database-provides-latest-global-data-on-cancer-burden-cancer-deaths/#:~:textual content=Feminine breast most cancers has now, with 685percent2C000 deaths in 2020. (2020).
Sofi, N., Jain, M., Kapil, U. & Yadav, C. Epidemiological traits of breast most cancers sufferers attending a tertiary health-care institute within the Nationwide Capital Territory of India. J. Most cancers Res. Ther. 15, 1087–1091 (2019).
Heer, E. et al. World burden and traits in premenopausal and postmenopausal breast most cancers: A population-based research. Lancet Glob. Heal. 8, e1027–e1037 (2020).
Schwartz, R. S. & Erban, J. Okay. Timing of metastasis in breast most cancers. N. Engl. J. Med. 376, 2486–2488 (2017).
Bray, F. et al. World most cancers statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 international locations. CA. Most cancers J. Clin. 68, 394–424 (2018).
Weledji, E. P. & Tambe, J. Breast most cancers detection and screening. Med. Clin. Rev. https://doi.org/10.21767/2471-299X.1000071 (2018).
Qiu, Y. et al. A a number of breast most cancers stem cell mannequin to foretell recurrence of T1–3, N0 breast most cancers. BMC Most cancers 19, 729 (2019).
Brenot-Rossi, I. et al. Nonvisualization of axillary sentinel node throughout lymphoscintigraphy: Is there a pathologic significance in breast most cancers?. J. Nucl. Med. 44, 1232–1237 (2003).
Gradishar, W. J. et al. Scientific observe pointers in oncology. JNCCN J. Natl. Compr. Most cancers Netw. 16, 310–320 (2018).
Kelley, M. C., Hansen, N. & McMasters, Okay. M. Lymphatic mapping and sentinel lymphadenectomy for breast most cancers. Am. J. Surg. 188, 49–61 (2004).
Krag, D. N., Weaver, D. L., Alex, J. C. & Fairbank, J. T. Surgical resection and radiolocalization of the sentinel lymph node in breast most cancers utilizing a gamma probe. Surg. Oncol. 2, 335–340 (1993).
Noguchi, M. et al. The position of axillary lymph node dissection in breast most cancers administration. Breast Most cancers 4, 143–153 (1997).
Erb, Okay. M. & Julian, T. B. Completion of axillary dissection for a optimistic sentinel node: Needed or not?. Curr. Oncol. Rep. 11, 15–20 (2009).
Borgstein, P. J. et al. Sentinel lymph node biopsy in breast most cancers: Tips and pitfalls of lymphoscintigraphy and gamma probe detection. J. Am. Coll. Surg. 186, 275–283 (1998).
van de Vijver, M. J. et al. A gene-expression signature as a predictor of survival in breast most cancers. N. Engl. J. Med. 347, 1999–2009 (2002).
Lorusso, G. & Rüegg, C. New insights into the mechanisms of organ-specific breast most cancers metastasis. Semin. Most cancers Biol. 22, 226–233 (2012).
Fry, S. A., Sinclair, J., Timms, J. F., Leathem, A. J. & Dwek, M. V. A focused glycoproteomic method identifies cadherin-5 as a novel biomarker of metastatic breast most cancers. Most cancers Lett. 328, 335–344 (2013).
Zeng, L. et al. Identification of nucleobindin-2 as a possible biomarker for breast most cancers metastasis utilizing iTRAQ-based quantitative proteomic evaluation. J. Most cancers. 8, 3062–3069 (2017).
Mokhtar, M. et al. Triple evaluation of sentinel lymph node metastasis in early breast most cancers utilizing preoperative CTLG, intraoperative fluorescence navigation and OSNA. Breast Most cancers 23, 202–210 (2016).
Zhao, Q. L. et al. Elastosonography and two-dimensional ultrasonography in analysis of axillary lymph node metastasis in breast most cancers. Clin. Radiol. 73, 312–318 (2018).
Solon, J. G., Energy, C., Al-Azawi, D., Duke, D. & Hill, A. D. Okay. Ultrasound-guided core biopsy: An efficient methodology of detecting axillary nodal metastases. J. Am. Coll. Surg. 214, 12–17 (2012).
Nandu, V. V. & Chaudhari, M. S. Efficacy of sentinel lymph node biopsy in detecting axillary metastasis in breast most cancers utilizing methylene blue. Indian J. Surg. Oncol. 8, 109–112 (2017).
Harada, T., Tanigawa, N., Matsuki, M., Nohara, T. & Narabayashi, I. Analysis of lymph node metastases of breast most cancers utilizing ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur. J. Radiol. 63, 401–407 (2007).
Roumen, R. M. H., Valkenburg, J. G. M. & Geuskens, L. M. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 sufferers with main breast most cancers. Eur. J. Surg. Oncol. 23, 495–502 (1997).
Gupta, A. Okay. et al. Cerebrospinal fluid proteomics for identification of α2-macroglobulin as a possible biomarker to observe pharmacological therapeutic efficacy in dopamine dictated illness states of Parkinson’s illness and schizophrenia. Neuropsychiatr. Dis. Deal with. 15, 2853–2867 (2019).
Pokhriyal, R., Hariprasad, R., Kumar, L. & Hariprasad, G. Chemotherapy resistance in superior ovarian most cancers sufferers. Biomark. Most cancers. 11, 1179299X1986081 (2019).
Pathania, S. et al. Proteomics of sentinel lymph nodes in early breast most cancers for identification of thymidylate synthase as a possible biomarker to flag metastasis: A preliminary research. Most cancers Manag. Res. 12, 4841–4854 (2020).
Kataria, Okay., Srivastava, A. & Qaiser, D. What Is a false destructive sentinel node biopsy: Definition, causes and methods to reduce it?. Indian J. Surg. 78, 396–401 (2016).
Orsburn, B. C. Proteome discoverer-a group enhanced knowledge processing suite for protein informatics. Proteomes 9, 1–13 (2021).
Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative evaluation of huge gene lists utilizing DAVID bioinformatics sources. Nat. Protoc. 4, 44–57 (2009).
Pang, Z. et al. MetaboAnalyst 5.0: Narrowing the hole between uncooked spectra and purposeful insights. Nucleic Acids Res. 49, W388–W396 (2021).
Kamradt, M. C., Chen, F. & Cryns, V. L. The small warmth shock protein αB-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J. Biol. Chem. 276, 16059–16063 (2001).
Mao, Y. W., Liu, J. P., Xiang, H. & Li, D. W. C. Human αA- and αB-crystallins bind to Bax and Bcl-Xs to sequester their translocation throughout staurosporine-induced apoptosis. Cell Dying Differ. 11, 512–526 (2004).
Liu, S. et al. As a novel p53 direct goal, bidirectional gene HspB2/αB-crystallin regulates the ROS stage and Warburg impact. Biochim. Biophys. Acta – Gene Regul. Mech. 1839, 592–603 (2014).
Shi, C. et al. Alpha B-crystallin correlates with poor survival in colorectal most cancers. Int. J. Clin. Exp. Pathol. 7, 6056–6063 (2014).
Mellone, M. et al. Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on most cancers prognosis. Ageing (Albany NY). 9, 114–132 (2017).
Hanley, C. J. et al. A subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber elongation, which is prognostic in a number of cancers. Oncotarget 7, 6159–6174 (2016).
Li, Y. et al. miR-181a-5p inhibits most cancers cell migration and angiogenesis by way of downregulation of matrix metalloproteinase-14. Most cancers Res. 75, 2674–2685 (2015).
Gonzalez-Avila, G. et al. Matrix metalloproteinases participation within the metastatic course of and their diagnostic and therapeutic functions in most cancers. Crit. Rev. Oncol. Hematol. 137, 57–83 (2019).
Nieto, M. A., Huang, R. Y. Y. J., Jackson, R. A. A. & Thiery, J. P. P. Emt: 2016. Cell 166, 21–45 (2016).
Ju, Q. et al. Identification of a miRNA-mRNA community related to lymph node metastasis in colorectal most cancers. Oncol. Lett. 18, 1179–1188 (2019).
Pike, L. J. Development issue receptors, lipid rafts and caveolae: An evolving story. Biochim. Biophys. Acta – Mol. Cell Res. 1746, 260–273 (2005).
Badana, A. Okay. et al. Lipid rafts disruption induces apoptosis by attenuating expression of LRP6 and survivin in triple destructive breast most cancers. Biomed. Pharmacother. 97, 359–368 (2018).
Wang, R. et al. Caveolin-1 features as a key regulator of 17β-estradiol-mediated autophagy and apoptosis in BT474 breast most cancers cells. Int. J. Mol. Med. 34, 822–827 (2014).
Bailey, Okay. M. & Liu, J. Caveolin-1 up-regulation throughout epithelial to mesenchymal transition is mediated by focal adhesion kinase. J. Biol. Chem. 283, 13714–13724 (2008).
Gai, X., Lu, Z., Tu, Okay., Liang, Z. & Zheng, X. Caveolin-1 is up-regulated by GLI1 and contributes to GLI1-driven EMT in hepatocellular carcinoma. PLoS One. 9, e84551 (2014).
Joglekar, M., Elbazanti, W. O., Weitzman, M. D., Lehman, H. L. & van Golen, Okay. L. Erratum to: Caveolin-1 mediates inflammatory breast most cancers cell invasion by way of the Akt1 pathway and RhoC GTPase: RhoC and caveolin -1 in inflammatory breast most cancers. J. Cell. Biochem. 118, 1273 (2017).
Li, S. et al. Shear stress promotes anoikis resistance of most cancers cells by way of caveolin-1-dependent extrinsic and intrinsic apoptotic pathways. J. Cell. Physiol. 234, 3730–3743 (2019).
Wang, Okay., Zhu, X., Chen, Y., Yin, Y. & Ma, T. Tubeimoside V sensitizes human triple destructive breast most cancers MDA-MB-231 cells to anoikis by way of regulating caveolin-1-related signaling pathways. Arch. Biochem. Biophys. 646, 10–15 (2018).
Kim, S. H. et al. Function of secreted kind I collagen derived from stromal cells in two breast most cancers cell traces. Oncol. Lett. 8, 507–512 (2014).
Liu, J. et al. Collagen 1A1 (COL1A1) promotes metastasis of breast most cancers and is a possible therapeutic goal. Discov. Med. 25, 211–223 (2018).
De Wever, O. & Mareel, M. Function of tissue stroma in most cancers cell invasion. Journal of Pathology. 200, 429–447 (2003).
Zilberberg, L. et al. Specificity of latent TGF-β binding protein (LTBP) incorporation into matrix: Function of fibrillins and fibronectin. J. Cell. Physiol. 227, 3828–3836 (2012).
Fuxe, J., Vincent, T. & De Herreros, A. G. Transcriptional crosstalk between TGFβ and stem cell pathways in tumor cell invasion: Function of EMT selling Smad complexes. Cell Cycle 9, 2363–2374 (2010).
Chaudhury, A. et al. TGF-Β-mediated phosphorylation of hnRNP E1 induces EMT by way of transcript-selective translational induction of Dab2 and ILEI. Nat. Cell Biol. 12, 286–293 (2010).
Liu, Okay. et al. Glyceraldehyde-3-phosphate dehydrogenase promotes most cancers development and metastasis by way of upregulation of SNAIL expression. Int. J. Oncol. 50, 252–262 (2017).
Calderwood, S. Okay. & Gong, J. Warmth shock proteins promote most cancers: It’s a safety racket. Traits Biochem. Sci. 41, 311–323 (2016).
Tsutsumi, S., Beebe, Okay. & Neckers, L. Affect of heat-shock protein 90 on most cancers metastasis. Future Oncol. 5, 679–688 (2009).
Shiota, M. et al. Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate most cancers. Most cancers Res. 73, 3109–3119 (2013).
Kim, W. H., Lee, B. L., Kim, D. Okay. & Kleinman, H. Okay. Laminin-1-adherent most cancers cells present elevated proliferation and decreased apoptosis in vivo. Anticancer Res. 19, 3067–3071 (1999).
Givant-Horwitz, V., Davidson, B. & Reich, R. Laminin-induced signaling in tumor cells. Most cancers Lett. 223, 1–10 (2005).
Wu, J. B. et al. Monoamine oxidase A mediates prostate tumorigenesis and most cancers metastasis. J. Clin. Make investments. 124, 2891–2908 (2014).
Albig, A. R., Becenti, D. J., Roy, T. G. & Schiemann, W. P. Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells. Microvasc. Res. 76, 7–14 (2008).
Yang, J. et al. Built-in evaluation of microfibrillar-associated proteins reveals MFAP4 as a novel biomarker in human cancers. Epigenomics 11, 5–21 (2019).
Huang, Y., Arora, P., McCulloch, C. A. & Vogel, W. F. The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA. J. Cell Sci. 122, 1637–1646 (2009).
Arjonen, A. et al. Mutant p53.related myosin-X upregulation promotes breast most cancers invasion and metastasis. J. Clin. Make investments. 124, 1069–1082 (2014).
Tirinato, L. et al. An outline of lipid droplets in most cancers and most cancers stem cells. Stem Cells Int. 2017, 1–17 (2017).
Chen, Y. F. et al. MicroRNA-211 enhances the oncogenicity of carcinogen-induced oral carcinoma by repressing TCF12 and rising antioxidant exercise. Most cancers Res. 76, 4872–4886 (2016).
Yu, H. et al. Transgelin is a direct goal of TGF-β/Smad3-dependent epithelial cell migration in lung fibrosis. FASEB J. 22, 1778–1789 (2008).
Lin, Y. et al. Affiliation of the actin-binding protein transgelin with lymph node metastasis in human colorectal most cancers. Neoplasia 11, 864–873 (2009).
Wu, X., Dong, L., Zhang, R., Ying, Okay. & Shen, H. Transgelin overexpression in lung adenocarcinoma is related to tumor development. Int. J. Mol. Med. 34, 585–591 (2014).
Borensztajn, Okay., Peppelenbosch, M. P. & Spek, C. A. Coagulation Issue Xa inhibits most cancers cell migration by way of LIMK1-mediated cofilin inactivation. Thromb. Res. 125, e323–e328 (2010).
Zhou, Z. J. et al. Hnrnpab induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by transcriptionally activating snail. Most cancers Res. 74, 2750–2762 (2014).
Stockley, J. et al. The RNA-binding protein hnRNPA2 regulates β-catenin protein expression and is overexpressed in prostate most cancers. RNA Biol. 11, 755–765 (2014).
Deng, J. et al. Results of hnRNP A2/B1 knockdown on inhibition of glioblastoma cell invasion, development and survival. Mol. Neurobiol. 53, 1132–1144 (2016).
Tauler, J., Zudaire, E., Liu, H., Shih, J. & Mulshine, J. L. hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung most cancers cell traces. Most cancers Res. 70, 7137–7147 (2010).
Bianchi, M. E. & Agresti, A. HMG proteins: Dynamic gamers in gene regulation and differentiation. Curr. Opin. Genet. Dev. 15, 496–506 (2005).
Medrzycki, M. et al. Histone H1.3 suppresses H19 noncoding RNA expression and cell development of ovarian most cancers cells. Most cancers Res. 74, 6463–6473 (2014).
Wang, J. et al. Cathelicidin suppresses colon most cancers metastasis by way of a P2RX7-dependent mechanism. Mol. Ther. – Oncolytics. 12, 195–203 (2019).
Kang, M. et al. miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells by way of downregulation of SOX4 expression. Int. J. Mol. Med. 32, 51–58 (2013).
Dransart, E., Olofsson, B. & Cherfils, J. RhoGDIs revisited: Novel roles in Rho regulation. Visitors 6, 957–966 (2005).
Hooper, J. A. et al. Purification and properties of Bovine Thymosin. Ann. N. Y. Acad. Sci. 249, 125–144 (1975).
Fan, Y.-z, Chang, H., Ye, Y., Liu, J. & Wang, R. Thymosin α1 suppresses proliferation and induces apoptosis in human leukemia cell traces. Peptides 27(9), 2165–2173. https://doi.org/10.1016/j.peptides.2006.03.012 (2006).
Williams, T. M. & Lisanti, M. P. The caveolin proteins. Genome Biol. 5, 214 (2004).
Xu, Y. et al. Endocytosis and membrane receptor internalization: Implication of F-BAR protein Carom. Entrance. Biosci. – Landmark. 22, 1439–1457 (2017).
Gajko-Galicka, A. Mutations in kind I collagen genes leading to osteogenesis imperfecta in people. Acta Biochim. Pol. 49, 433–441 (2002).
Gelse, Okay., Pöschl, E. & Aigner, T. Collagens – Construction, operate, and biosynthesis. Adv. Drug Deliv. Rev. 55, 1531–1546 (2003).
Paulin, D. & Li, Z. Desmin: A serious intermediate filament protein important for the structural integrity and performance of muscle. Exp. Cell Res. 301, 1–7 (2004).
Shah, S. B. et al. Structural and purposeful roles of desmin in mouse skeletal muscle throughout passive deformation. Biophys. J. 86, 2993–3008 (2004).
Sakai, L. Y., Keene, D. R., Renard, M. & De Backer, J. FBN1: The disease-causing gene for Marfan syndrome and different genetic issues. Gene 592, 279–291 (2016).
Schrenk, S., Cenzi, C., Bertalot, T., Conconi, M. T. & Di Liddo, R. Structural and purposeful failure of fibrillin-1 in human illnesses (Assessment). Int. J. Mol. Med. 41, 1213–1223 (2018).
Pilecki, B. et al. Characterization of microfibrillar-associated protein 4 (MFAP4) as a tropoelastin- and fibrillin-binding protein concerned in elastic fiber formation. J. Biol. Chem. 291, 1103–1114 (2016).
Kielty, C. M. Fell-Muir lecture: Fibrillin microfibrils: structural tensometers of elastic tissues?. Int. J. Exp. Pathol. 98, 172–190 (2017).
Morgado, F. N., da Silva, A. V. A. & Porrozzi, R. Infectious illnesses and the lymphoid extracellular matrix transforming: A concentrate on conduit system. Cells 9, 1–13 (2020).
Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A. & Fares, Y. Molecular rules of metastasis: A trademark of most cancers revisited. Sign Transduct. Goal. Ther. https://doi.org/10.1038/s41392-020-0134-x (2020).
Wiig, H., Keskin, D. & Kalluri, R. Interplay between the extracellular matrix and lymphatics: Penalties for lymphangiogenesis and lymphatic operate. Matrix Biol. 29, 645–656 (2010).
Kaushik, S., Pickup, M. W. & Weaver, V. M. From transformation to metastasis: Deconstructing the extracellular matrix in breast most cancers. Most cancers Metastasis Rev. 35, 655–667 (2016).
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, Okay. J. & Werb, Z. Ideas of extracellular matrix remodelling in tumour development and metastasis. Nat. Commun. 11, 1–17 (2020).
Ecker, B. L. et al. Age-related modifications in HAPLN1 improve lymphatic permeability and have an effect on routes of melanoma metastasis. Most cancers Discov. 9, 82–95 (2019).
Paszek, M. J. et al. Tensional homeostasis and the malignant phenotype. Most cancers Cell 8, 241–254 (2005).
Frantz, C., Stewart, Okay. M. & Weaver, V. M. The extracellular matrix at a look. J. Cell Sci. 123, 4195–4200 (2010).
Erdogan, B. & Webb, D. J. Most cancers-associated fibroblasts modulate development issue signaling and extracellular matrix transforming to control tumor metastasis. Biochem. Soc. Trans. 45, 229–236 (2017).
Kortum, R. L. et al. Caveolin-1 is required for kinase suppressor of Ras 1 (KSR1)-mediated extracellular signal-regulated kinase 1/2 activation, H-Ras V12 -induced senescence, and transformation. Mol. Cell. Biol. 34, 3461–3472 (2014).
Zhang, H. et al. LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic most cancers by regulating the PI3K/Akt signaling pathway. Cell Dying Dis. https://doi.org/10.1038/s41419-019-1320-z (2019).
Xia, P., Liu, Y. & Cheng, Z. Signaling pathways in cardiac myocyte apoptosis. Biomed. Res. Int. 2016, 1–22 (2016).
Mecham, R. P. & Gibson, M. A. The microfibril-associated glycoproteins (MAGPs) and the microfibrillar area of interest. Matrix Biol. 47, 13–33 (2015).
Xiong, H. et al. Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal most cancers cells. Neoplasia 10, 287–297 (2008).
Deutsch, E. W. et al. The ProteomeXchange consortium in 2020: Enabling ‘massive knowledge’ approaches in proteomics. Nucleic Acids Res. 48, D1145–D1152 (2020).